Table 2.
Time-action of intermediate-acting and long-acting insulins (100 U/mL).
| Insulin Type | Brand name | Onset of Action (hr)a | Peak Action (hr) | Duration of Action (hr) |
|---|---|---|---|---|
| Intermediate-acting U-100 | ||||
| NPH insulin | Humulin® N (40), Novolin® N (41) | 1–2 | 2–8 | 14–24 |
| Long-acting U-100 | ||||
| Insulin glargine | Lantus® (43), Basaglar® | NA | No pronounced peak | 24 |
| Insulin detemir | Levemir® (52) | NA | No pronounced peak | 7.6–>24 |
| Insulin degludec | Tresiba® (59) | NA | No pronounced peak | 42 |
a The onset of action is not relevant for long-acting insulins.